Stacy Feld

Bio

Stacy Feld is a Director at Physic Ventures. Stacy focuses on personalized health solutions to improve and transform care for the health consumer. Specifically, Stacy is interested in life science opportunities offering more precise prevention, diagnosis, and treatment of chronic disease. She is on the board of T2 Biosystems and an observer on the On-Q-ity board. Stacy brings to Physic over ten years of transactional experience in the life science and healthcare industries. Prior to joining Physic, Stacy was Associate Director of Business Development at Genentech, Inc., where she focused on sourcing and accessing novel therapies and predictive diagnostics in the areas of Oncology, Immunology, Ophthalmology, Vascular Biology and Metabolic Diseases. While at Genentech, she worked to establish multiple disease area strategies for the company and led collaboration teams for the evaluation and execution of strategic partnerships and licensing arrangements. Formerly, Stacy was Director of Licensing and Corporate Development at Third Wave Technologies, Inc., a molecular diagnostics company (since acquired by Hologic, Inc. in2008), where she was responsible for in-licensing intellectual property to support product development and building strategic relationships with customers, collaborators and suppliers. Stacy began her career in life sciences as an Associate at Wilson Sonsini Goodrich and Rosati in Palo Alto, CA. As an attorney in the firm's Technology Transactions practice, she advised start-ups and mature companies in the biopharmaceutical and medical device sectors on intellectual property matters and strategic business transactions. Stacy received a B.A. in Sociology, graduating magna cum laude from the University of Pennsylvania and earned her J.D. from Vanderbilt Law School.